(Q40152886)

English

Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial

scientific article published on 22 November 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

8

object named as

Joseph Bresee

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Larisa Gubareva

6

object named as

Larisa Gubareva

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1

object named as

Alicia M Fry

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

author name string

Doli Goswami

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Kamrun Nahar

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Amina Tahia Sharmin

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Mustafizur Rahman

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Tasnim Azim

7

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

W Abdullah Brooks

10

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

publication date

22 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Lancet Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

109-118

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral oseltamivir treatment of influenza in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Influenza is a major contributor to childhood pneumonia in a tropical developing country

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Should staff in long-stay hospitals for elderly patients be vaccinated against influenza?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral loads and duration of viral shedding in adult patients hospitalized with influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of adults hospitalised with severe influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of influenza A virus shedding in hospitalized patients and implications for infection control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of Shedding of Myxoviruses and Paramyxoviruses in Children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral Shedding Patterns of Children with Influenza B Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The Tecumseh Study of Respiratory Illness. IX. Occurence of influenza in the community, 1966--1971

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970267-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(13)70267-6

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40152886&oldid=1887389107"